Skip to main content

A Patient with a Large Minimally Invasive Follicular Thyroid Cancer

  • Chapter
Thyroid Cancer

Abstract

Follicular thyroid cancer (FTC) is a differentiated thyroid cancer, representing 5.5 % of all thyroid cancers. FTC is histologically subclassified according to its degree of invasiveness into either a minimally invasive follicular cancer (MIFC) or a widely invasive follicular thyroid cancer (WIFC). According to the World Health Organization (WHO), MIFC presents with unequivocal invasion of the blood vessels within or immediately outside of the tumor capsule and/or invasion that fully penetrates the thickness of the capsule, whereas WIFC is characterized by widespread infiltration of blood vessels and/or surrounding parenchyma and tissue. However, the diagnostic criteria for MIFC are still controversial which has led to differing recommendations as to the appropriate extent of treatment for patients with MIFC, ranging from thyroid lobectomy alone to total thyroidectomy and postoperative radioactive iodine ablation (RAI).

Several studies have shown compromised disease-free survival and cause-specific mortality of WIFC as compared to MIFC. Tumor size ≥4 cm, patient age ≥45 years, presence of vascular invasion, and nodal and distant metastases have been identified as negative prognostic factors. Current practice guidelines are inconsistent in their recommendations about optimal management approach for MIFC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. SEER Cancer Statistics Review 1975–2011. Cancer of the Thyroid (Invasive). http://seer.cancer.gov/csr/1975_2011/browse_csr.php?sectionSEL=26&pageSEL=sect_26_table.22.html. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program; 2014 (cited 1 Aug 2014).

  2. Franssila KO, Ackerman LV, Brown CL, Hedinger CE. Follicular carcinoma. Semin Diagn Pathol. 1985;2(2):101–22.

    CAS  PubMed  Google Scholar 

  3. DeLellis RALR, Heitz PU, Eng C. WHO classification of tumours, pathology and genetics of tumours of endocrine organs. 1st ed. Lyon: World Health Organization/IARC Press; 2004.

    Google Scholar 

  4. Hedinger CEWE, Sobin LH. Histological typing of thyroid tumours. International histological classification of tumours, vol. 11. Berlin: Springer; 1988.

    Book  Google Scholar 

  5. Goffredo P, Roman SA, Sosa JA. Hurthle cell carcinoma: a population-level analysis of 3311 patients. Cancer. 2013;119(3):504–11.

    Article  PubMed  Google Scholar 

  6. Huang CC, Hsueh C, Liu FH, Chao TC, Lin JD. Diagnostic and therapeutic strategies for minimally and widely invasive follicular thyroid carcinomas. Surg Oncol. 2011;20(1):1–6.

    Article  PubMed  Google Scholar 

  7. D’Avanzo A, Treseler P, Ituarte PH, Wong M, Streja L, Greenspan FS, et al. Follicular thyroid carcinoma: histology and prognosis. Cancer. 2004;100(6):1123–9.

    Article  PubMed  Google Scholar 

  8. Ghossein R. Update to the College of American Pathologists reporting on thyroid carcinomas. Head Neck Pathol. 2009;3(1):86–93.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Carcangiu ML. Minimally invasive follicular carcinoma. Endocr Pathol. 1997;8(3):231–4.

    Article  PubMed  Google Scholar 

  10. Heffess CS, Thompson LD. Minimally invasive follicular thyroid carcinoma. Endocr Pathol. 2001;12(4):417–22.

    Article  CAS  PubMed  Google Scholar 

  11. van Heerden JA, Hay ID, Goellner JR, Salomao D, Ebersold JR, Bergstralh EJ, et al. Follicular thyroid carcinoma with capsular invasion alone: a nonthreatening malignancy. Surgery. 1992;112(6):1130–6. discussion 6–8.

    PubMed  Google Scholar 

  12. Baloch ZW, LiVolsi VA. Follicular-patterned afflictions of the thyroid gland: reappraisal of the most discussed entity in endocrine pathology. Endocr Pathol. 2014;25(1):12–20.

    Article  CAS  PubMed  Google Scholar 

  13. Thompson LD, Wieneke JA, Paal E, Frommelt RA, Adair CF, Heffess CS. A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature. Cancer. 2001;91(3):505–24.

    Article  CAS  PubMed  Google Scholar 

  14. Rosai JCM, DeLellis RA. Tumours of the thyroid gland. Atlas of tumor pathology 3rd series, fascicle 5. Washington: Armed Forces Institute of Pathology; 1992. p. 49–63.

    Google Scholar 

  15. Hermann M, Tonninger K, Kober F, Furtlehner EM, Schultheis A, Neuhold N. [Minimally invasive follicular thyroid carcinoma: Not always total thyroidectomy]. Chirurg. 2010;81(7):627–30. 632–5.

    Article  CAS  PubMed  Google Scholar 

  16. Rosai J. Handling of thyroid follicular patterned lesions. Endocr Pathol. 2005;16(4):279–83.

    Article  PubMed  Google Scholar 

  17. Lang BH, Lo CY, Chan WF, Lam KY, Wan KY. Staging systems for follicular thyroid carcinoma: application to 171 consecutive patients treated in a tertiary referral centre. Endocr Relat Cancer. 2007;14(1):29–42.

    Article  PubMed  Google Scholar 

  18. Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol. 2002;117(1):143–50.

    Article  PubMed  Google Scholar 

  19. Raman P, Koenig RJ. Pax-8-PPAR-gamma fusion protein in thyroid carcinoma. Nat Rev Endocrinol. 2014;10:616–23.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Bhaijee F, Nikiforov YE. Molecular analysis of thyroid tumors. Endocr Pathol. 2011;22(3):126–33.

    Article  CAS  PubMed  Google Scholar 

  21. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009;94(6):2092–8.

    Article  CAS  PubMed  Google Scholar 

  22. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.

    Article  PubMed  Google Scholar 

  23. Laury AR, Bongiovanni M, Tille JC, Kozakewich H, Nose V. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity. Thyroid. 2011;21(2):135–44.

    Article  PubMed  Google Scholar 

  24. Hunt JL, Livolsi VA, Baloch ZW, Swalsky PA, Bakker A, Sasatomi E, et al. A novel microdissection and genotyping of follicular-derived thyroid tumors to predict aggressiveness. Hum Pathol. 2003;34(4):375–80.

    Article  CAS  PubMed  Google Scholar 

  25. Lubitz CC, Gallagher LA, Finley DJ, Zhu B, Fahey 3rd TJ. Molecular analysis of minimally invasive follicular carcinomas by gene profiling. Surgery. 2005;138(6):1042–8. discussion 8–9.

    Article  PubMed  Google Scholar 

  26. Jikuzono T, Kawamoto M, Yoshitake H, Kikuchi K, Akasu H, Ishikawa H, et al. The miR-221/222 cluster, miR-10b and miR-92a are highly upregulated in metastatic minimally invasive follicular thyroid carcinoma. Int J Oncol. 2013;42(6):1858–68.

    PubMed Central  CAS  PubMed  Google Scholar 

  27. Ito Y, Hirokawa M, Masuoka H, Yabuta T, Kihara M, Higashiyama T, et al. Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis. Endocr J. 2013;60(5):637–42.

    Article  PubMed  Google Scholar 

  28. Ito Y, Hirokawa M, Masuoka H, Yabuta T, Fukushima M, Kihara M, et al. Distant metastasis at diagnosis and large tumor size are significant prognostic factors of widely invasive follicular thyroid carcinoma. Endocr J. 2013;60(6):829–33.

    Article  PubMed  Google Scholar 

  29. Goffredo P, Cheung K, Roman SA, Sosa JA. Can minimally invasive follicular thyroid cancer be approached as a benign lesion?: a population-level analysis of survival among 1,200 patients. Ann Surg Oncol. 2013;20(3):767–72.

    Article  PubMed  Google Scholar 

  30. Sugino K, Kameyama K, Ito K, Nagahama M, Kitagawa W, Shibuya H, et al. Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma. Thyroid. 2012;22(8):798–804.

    Article  PubMed  Google Scholar 

  31. Cho SW, Choi HS, Yeom GJ, Lim JA, Moon JH, Park YJ, et al. Long-term prognosis of differentiated thyroid cancer with lung metastasis in Korea and its prognostic factors. Thyroid. 2014;24(2):277–86.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Tran Cao HS, Johnston LE, Chang DC, Bouvet M. A critical analysis of the American Joint Committee on Cancer (AJCC) staging system for differentiated thyroid carcinoma in young patients on the basis of the surveillance, epidemiology, and end results (SEER) registry. Surgery. 2012;152(2):145–51.

    Article  PubMed Central  PubMed  Google Scholar 

  33. Staging information for thyroid cancer http://cancer.gov/cancertopics/pdq/treatment/thyroid/HealthProfessional/page3: National Cancer Institute; 2014 (cited 1 Jun 2014).

    Google Scholar 

  34. Ito Y, Miyauchi A, Tomoda C, Hirokawa M, Kobayashi K, Miya A. Prognostic significance of patient age in minimally and widely invasive follicular thyroid carcinoma: investigation of three age groups. Endocr J. 2014;61(3):265–71.

    Article  PubMed  Google Scholar 

  35. Kim HJ, Sung JY, Oh YL, Kim JH, Son YI, Min YK, et al. Association of vascular invasion with increased mortality in patients with minimally invasive follicular thyroid carcinoma but not widely invasive follicular thyroid carcinoma. Head Neck 2014;36(12):1695–700.

    Google Scholar 

  36. Goldstein NS, Czako P, Neill JS. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients. Mod Pathol. 2000;13(2):123–30.

    Article  CAS  PubMed  Google Scholar 

  37. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A national cancer data base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995 (see comments). Cancer. 1998;83(12):2638–48.

    Article  CAS  PubMed  Google Scholar 

  38. Haigh PI, Urbach DR. The treatment and prognosis of Hurthle cell follicular thyroid carcinoma compared with its non-Hurthle cell counterpart. Surgery. 2005;138(6):1152–7. discussion 7–8.

    Article  PubMed  Google Scholar 

  39. O’Neill CJ, Vaughan L, Learoyd DL, Sidhu SB, Delbridge LW, Sywak MS. Management of follicular thyroid carcinoma should be individualised based on degree of capsular and vascular invasion. Eur J Surg Oncol. 2011;37(2):181–5.

    Article  PubMed  Google Scholar 

  40. Collini P, Sampietro G, Rosai J, Pilotti S. Minimally invasive (encapsulated) follicular carcinoma of the thyroid gland is the low-risk counterpart of widely invasive follicular carcinoma but not of insular carcinoma. Virchows Arch. 2003;442(1):71–6.

    PubMed  Google Scholar 

  41. Shaha AR. Invited commentary: minimally invasive follicular thyroid carcinoma. Surgery. 2001;130(1):119–20.

    Article  CAS  PubMed  Google Scholar 

  42. Ban EJ, Andrabi A, Grodski S, Yeung M, McLean C, Serpell J. Follicular thyroid cancer: minimally invasive tumours can give rise to metastases. ANZ J Surg. 2012;82(3):136–9.

    Article  PubMed  Google Scholar 

  43. Delbridge L, Parkyn R, Philips J, Barraclough B, Robinson B. Minimally invasive follicular thyroid carcinoma: completion thyroidectomy or not? ANZ J Surg. 2002;72(11):844–5.

    Article  PubMed  Google Scholar 

  44. Sugino K, Kameyama K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, et al. Does completion thyroidectomy improve the outcome of patients with minimally invasive follicular carcinoma of the thyroid? Ann Surg Oncol. 2014;21(9):2981–6.

    Article  PubMed  Google Scholar 

  45. Dionigi G, Kraimps JL, Schmid KW, Hermann M, Sheu-Grabellus SY, De Wailly P, et al. Minimally invasive follicular thyroid cancer (MIFTC)—a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbeck’s Arch Surg. 2014;399(2):165–84.

    Article  Google Scholar 

  46. NCCN guidelines: thyroid carcinoma. https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/PDF/thyroid.pdf. National Comprehensive Cancer Network 2012 (cited 1 Aug 2014).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tracy S. Wang MD, MPH .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Wang, T.S., Goffredo, P., Sosa, J.A. (2016). A Patient with a Large Minimally Invasive Follicular Thyroid Cancer. In: Cooper, D., Durante, C. (eds) Thyroid Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-22401-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-22401-5_10

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-22400-8

  • Online ISBN: 978-3-319-22401-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics